SHELIA CHAPMAN: Open Payments
NPI 1265939078 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 26 payments from 7 companies in 2025. Trend: 2023 $1,180 · 2024 $998 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $348 |
| Hologic Sales and Service, LLC | 3 | $116 |
| Exeltis, USA Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: BOTOX, ACESSA PROVU SYSTEM, SLYND, APTIMA, Veozah, ZURZUVAE, INJECTAFER, CoolSeal Generator.
Industry payments across NV — which companies pay providers there.
